Publication | Closed Access

SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes

Signal TransductionHepatologySignaling PathwayMolecular PathwayMedicineLiver PhysiologyPrimary CulturesHepatotoxicityJnk MapPharmacologyCell BiologyCell SignalingPharmacological Inhibitor